Cumberland Pharmaceuticals (CPIX) Amortization of Deferred Charges (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Amortization of Deferred Charges across 17 years of filings, most recently posting $5173.0 for Q1 2026.

• Amortization of Deferred Charges for Q1 2026 came in at $5173.0, down 3.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $22996.0 (down 23.0% YoY), and the FY2025 annual result was $23185.0, down 18.11% from the prior year.
• Amortization of Deferred Charges came in at $5173.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $7100.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $10723.0 in Q3 2024 to a low of $2183.0 in Q1 2022.
• The 5-year median for Amortization of Deferred Charges is $4296.0 (2023), against an average of $4907.7.
• Peak annual rise in Amortization of Deferred Charges reached 3199.09% in 2022, while the deepest fall reached 84.22% in 2022.
• Cumberland Pharmaceuticals' Amortization of Deferred Charges stood at $3629.0 in 2022, then increased by 4.99% to $3810.0 in 2023, then surged by 134.54% to $8936.0 in 2024, then fell by 20.55% to $7100.0 in 2025, then decreased by 27.14% to $5173.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $5173.0 (Q1 2026), $7100.0 (Q4 2025), and $5362.0 (Q3 2025), per Business Quant data.